Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
5.95
+0.16 (2.76%)
Feb 19, 2026, 4:00 PM EST - Market closed

Kazia Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
4.351.665.247.3627.59
Cash & Short-Term Investments
4.351.665.247.3627.59
Cash Growth
162.22%-68.38%-28.80%-73.32%214.77%
Accounts Receivable
--0--
Other Receivables
0.090.130.10.050.08
Receivables
0.090.130.110.050.08
Prepaid Expenses
0.490.591.6321.72
Other Current Assets
0.013.763.790.040.01
Total Current Assets
4.936.1510.779.4529.39
Other Intangible Assets
1.0915.417.2719.1422
Other Long-Term Assets
0.040.040.047.36.69
Total Assets
6.0621.5928.0835.8958.09
Accounts Payable
5.654.550.861.521.89
Accrued Expenses
4.8610.884.162.63.27
Short-Term Debt
0.40.631.81.84-
Other Current Liabilities
3.159.730.750.763.16
Total Current Liabilities
14.0525.87.576.738.33
Pension & Post-Retirement Benefits
0.040.040.060.120.05
Long-Term Deferred Tax Liabilities
0.272.022.292.562.93
Other Long-Term Liabilities
-3.756.128.218.93
Total Liabilities
14.3631.616.0317.6120.24
Common Stock
123.05101.6497.4584.4880.29
Retained Earnings
-134.83-115.13-89.08-68.62-44.2
Comprehensive Income & Other
3.483.483.682.411.76
Total Common Equity
-8.3-10.0212.0518.2737.85
Shareholders' Equity
-8.3-10.0212.0518.2737.85
Total Liabilities & Equity
6.0621.5928.0835.8958.09
Total Debt
0.40.631.81.84-
Net Cash (Debt)
3.951.023.455.5227.59
Net Cash Growth
286.02%-70.30%-37.59%-79.99%214.77%
Net Cash Per Share
3.601.949.3520.84117.22
Filing Date Shares Outstanding
1.830.870.470.30.26
Total Common Shares Outstanding
1.620.670.460.280.26
Working Capital
-9.12-19.653.212.7221.06
Book Value Per Share
-5.13-15.0526.4265.85143.36
Tangible Book Value
-9.39-25.42-5.22-0.8615.85
Tangible Book Value Per Share
-5.80-38.18-11.44-3.1160.03
Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q